These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 16037301

  • 1. From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.
    Miyata T, Yamamoto M, Izuhara Y.
    Ann N Y Acad Sci; 2005 Jun; 1043():740-9. PubMed ID: 16037301
    [Abstract] [Full Text] [Related]

  • 2. A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic rats.
    Izuhara Y, Sada T, Yanagisawa H, Koike H, Ohtomo S, Dan T, Ito S, Nangaku M, van Ypersele de Strihou C, Miyata T.
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1767-73. PubMed ID: 18658044
    [Abstract] [Full Text] [Related]

  • 3. A novel class of advanced glycation inhibitors ameliorates renal and cardiovascular damage in experimental rat models.
    Izuhara Y, Nangaku M, Takizawa S, Takahashi S, Shao J, Oishi H, Kobayashi H, van Ypersele de Strihou C, Miyata T.
    Nephrol Dial Transplant; 2008 Feb; 23(2):497-509. PubMed ID: 17928329
    [Abstract] [Full Text] [Related]

  • 4. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP, Pang YJ, Zhu WW, Zhao TT, Zheng M, Wang YB, Sun ZJ, Sun SJ.
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of advanced glycation end products (AGEs): an implicit goal in clinical medicine for the treatment of diabetic nephropathy?
    Miyata T, Dan T.
    Diabetes Res Clin Pract; 2008 Nov 13; 82 Suppl 1():S25-9. PubMed ID: 18954918
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of advanced glycation end products: an implicit goal in clinical medicine for the treatment of diabetic nephropathy?
    Miyata T, Izuhara Y.
    Ann N Y Acad Sci; 2008 Apr 13; 1126():141-6. PubMed ID: 18448808
    [Abstract] [Full Text] [Related]

  • 7. A detective story for biomedical footprints towards new therapeutic interventions in diabetic nephropathy.
    Miyata T, Kurokawa K.
    Intern Med; 2003 Dec 13; 42(12):1165-71. PubMed ID: 14714952
    [Abstract] [Full Text] [Related]

  • 8. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
    Watanabe D, Tanabe A, Naruse M, Morikawa S, Ezaki T, Takano K.
    Hypertens Res; 2009 Sep 13; 32(9):807-15. PubMed ID: 19662019
    [Abstract] [Full Text] [Related]

  • 9. Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?
    Coughlan MT, Cooper ME, Forbes JM.
    Ann N Y Acad Sci; 2005 Jun 13; 1043():750-8. PubMed ID: 16037302
    [Abstract] [Full Text] [Related]

  • 10. TRC4149 a novel advanced glycation end product breaker improves hemodynamic status in diabetic spontaneously hypertensive rats.
    Pathak P, Gupta R, Chaudhari A, Shiwalkar A, Dubey A, Mandhare AB, Gupta RC, Joshi D, Chauthaiwale V.
    Eur J Med Res; 2008 Aug 18; 13(8):388-98. PubMed ID: 18952522
    [Abstract] [Full Text] [Related]

  • 11. In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy.
    Nangaku M, Izuhara Y, Usuda N, Inagi R, Shibata T, Sugiyama S, Kurokawa K, van Ypersele de Strihou C, Miyata T.
    Nephrol Dial Transplant; 2005 Dec 18; 20(12):2661-9. PubMed ID: 16188903
    [Abstract] [Full Text] [Related]

  • 12. The angiotensin-II (AT-II) receptor blocker olmesartan reduces renal damage in animal models of hypertension and diabetes.
    Pugsley MK.
    Proc West Pharmacol Soc; 2005 Dec 18; 48():35-8. PubMed ID: 16416656
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats.
    Portero-Otín M, Pamplona R, Boada J, Jové M, Gonzalo H, Buleon M, Linz W, Schäfer S, Tack I, Girolami JP.
    Biochem Biophys Res Commun; 2008 Apr 11; 368(3):528-35. PubMed ID: 18243127
    [Abstract] [Full Text] [Related]

  • 14. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats.
    Boor P, Celec P, Behuliak M, Grancic P, Kebis A, Kukan M, Pronayová N, Liptaj T, Ostendorf T, Sebeková K.
    Metabolism; 2009 Nov 11; 58(11):1669-77. PubMed ID: 19608208
    [Abstract] [Full Text] [Related]

  • 15. Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering.
    Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, Kurokawa K, van Ypersele de Strihou C, Miyata T.
    J Am Soc Nephrol; 2005 Dec 11; 16(12):3631-41. PubMed ID: 16236804
    [Abstract] [Full Text] [Related]

  • 16. A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage.
    Takizawa S, Dan T, Uesugi T, Nagata E, Takagi S, van Ypersele de Strihou C, Miyata T.
    J Cereb Blood Flow Metab; 2009 Oct 11; 29(10):1665-72. PubMed ID: 19536069
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM.
    Diabetes; 2008 Feb 11; 57(2):460-9. PubMed ID: 17959934
    [Abstract] [Full Text] [Related]

  • 18. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
    Osawa T, Kato Y.
    Ann N Y Acad Sci; 2005 Jun 11; 1043():440-51. PubMed ID: 16037265
    [Abstract] [Full Text] [Related]

  • 19. Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors.
    Sugimoto H, Grahovac G, Zeisberg M, Kalluri R.
    Diabetes; 2007 Jul 11; 56(7):1825-33. PubMed ID: 17456853
    [Abstract] [Full Text] [Related]

  • 20. Renoprotective effects of a novel inhibitor of advanced glycation.
    Forbes JM, Soulis T, Thallas V, Panagiotopoulos S, Long DM, Vasan S, Wagle D, Jerums G, Cooper ME.
    Diabetologia; 2001 Jan 11; 44(1):108-14. PubMed ID: 11206401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.